Aleksandar Bartolome

Aleksandar Bartolome

Auto-generated profile, based on publicly available information

Aleksandar Bartolome

Leibniz Institute on Aging - Fritz Lipmann Institute (FLI)

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2020 in Molecular Systems Biology
Verified
Journal Article
Open access
PDF file
ESErika Kelmer Sacramento
Erika Kelmer Sacramento
JKJoanna M Kirkpatrick
Joanna M Kirkpatrick
MMMariateresa Mazzetto
Mariateresa Mazzetto
MBMario Baumgart
Mario Baumgart
ABAleksandar Bartolome
Aleksandar Bartolome
AOAlessandro Ori
Alessandro Ori
A progressive loss of protein homeostasis is characteristic of aging and a driver of neurodegeneration. To investigate this process quantitatively, we characterized proteome dynamics during brain aging in the short‐lived vertebrate Nothobranchius furzeri combining transcriptomics and proteomics. We detected a progressive reduction in the correlation between protein and mRNA, mainly due to post‐transcriptional mechanisms that account for over 40% of the age‐regulated proteins. These changes cause a progressive loss of stoichiometry in several protein complexes, including ribosomes, which show impaired assembly/disassembly and are enriched in protein aggregates in old brains. Mechanistically, we show that reduction of proteasome activity is an early event during brain aging and is sufficient to induce proteomic signatures of aging and loss of stoichiometry in vivo . Using longitudinal transcriptomic data, we show that the magnitude of early life decline in proteasome levels is a major risk factor for mortality. Our work defines causative events in the aging process that can be targeted to prevent loss of protein homeostasis and delay the onset of age‐related neurodegeneration.

17 April 2018 in International Journal of Experimental Pathology
Verified
Journal Article
Closed access
PDF file
SSSonja Selemetjev
Sonja Selemetjev
ABAleksandar Bartolome
Aleksandar Bartolome
TDTijana Išić Denčić
Tijana Išić Denčić
IĐIlona Đorić
Ilona Đorić
IPIvan Paunović
Ivan Paunović
DCDubravka Cvejić
Dubravka Cvejić


1 October 2018 in Experimental and Molecular Pathology
Verified
Journal Article
Closed access
TDTijana Išić Denčić
Tijana Išić Denčić
ABAleksandar Bartolome
Aleksandar Bartolome
SSSonja Selemetjev
Sonja Selemetjev
IĐIlona Đorić
Ilona Đorić
STSvetislav Tatić
Svetislav Tatić
DCDubravka Cvejić
Dubravka Cvejić

9 August 2022 in bioRxiv
Verified
Preprint
Open access
PDF file
ABAleksandar Bartolome
Aleksandar Bartolome
JHJulia C. Heiby
Julia C. Heiby
DFDomenico Di Fraia
Domenico Di Fraia
IHIvonne Heinze
Ivonne Heinze
HKHannah Knaudt
Hannah Knaudt
AOAlessandro Ori
Alessandro Ori
SUMMARY: Proteasomes are essential molecular machines responsible for the degradation of proteins in eukaryotic cells. Altered proteasome activity has been linked to neurodegeneration, auto-immune disorders and cancer. Despite the relevance for human disease and drug development, no method currently exists to monitor proteasome composition and interactions in vivo in animal models. To fill this gap, we developed a strategy based on tagging of proteasomes with promiscuous biotin ligases and generated a new mouse model enabling the quantification of proteasome interactions by mass spectrometry. We show that biotin ligases can be incorporated in fully assembled proteasomes without negative impact on their activity. We demonstrate the utility of our method by identifying novel proteasome-interacting proteins, charting interactomes across mouse organs, and showing that proximity-labeling enables the identification of both endogenous and small molecule-induced proteasome substrates.

1 May 2024 in eLife preprints
Verified
Preprint
Open access
PDF file
ABAleksandar Bartolome
Aleksandar Bartolome
JHJulia C. Heiby
Julia C. Heiby
DFDomenico Di Fraia
Domenico Di Fraia
IHIvonne Heinze
Ivonne Heinze
HKHannah Knaudt
Hannah Knaudt
AOAlessandro Ori
Alessandro Ori
Summary Proteasomes are essential molecular machines responsible for the degradation of proteins in eukaryotic cells. Altered proteasome activity has been linked to neurodegeneration, auto-immune disorders and cancer. Despite the relevance for human disease and drug development, no method currently exists to monitor proteasome composition and interactions in vivo in animal models. To fill this gap, we developed a strategy based on tagging of proteasomes with promiscuous biotin ligases and generated a new mouse model enabling the quantification of proteasome interactions by mass spectrometry. We show that biotin ligases can be incorporated in fully assembled proteasomes without negative impact on their activity. We demonstrate the utility of our method by identifying novel proteasome-interacting proteins, charting interactomes across mouse organs, and showing that proximity-labeling enables the identification of both endogenous and small molecule-induced proteasome substrates.